Since expression of SphK1 in the triple negative (TN) cancer cell line, MDA-MB-231 was upregulated in stiff substrate in our results, we anticipated that breast cancer cells would increase SphK1 levels in stiff substrates. Here, SPHK1 is linked to breast carcinoma.